Business Context and Reporting Period
Company: OrthoPediatrics Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: April 30, 2026
Reporting Period: This filing reports on events occurring on April 30, 2026, specifically regarding upcoming investor presentations.
Financial Metrics
This Form 8-K does not contain financial statements, revenue figures, profit data, cash flow, margins, debt levels, or liquidity metrics. The filing serves solely to disclose the use of an investor presentation for upcoming meetings.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing indicates that executive officers intend to use the material in Exhibit 99.1 (Investor Presentation dated April 2026) for upcoming presentations to investors and analysts.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms upcoming presentations by executive officers to representatives of investors and analysts.
Regulatory Disclosure: The information provided, including the referenced Exhibit 99.1, is furnished pursuant to Item 7.01 of Regulation FD and is not deemed "filed" under Section 18 of the Exchange Act. It is not incorporated by reference into other filings unless expressly stated.
Risks and Contingencies: No specific risks or contingencies are detailed in this filing text.
Key Facts for Investor Verification
- Verify the contents of Exhibit 99.1 (OrthoPediatrics Corp. Investor Presentation dated April 2026) for actual financial data and guidance, as this 8-K only references it.
- Confirm the dates and details of the upcoming investor presentations mentioned by executive officers.
- Note that the information in this filing is not legally "filed" for liability purposes under Section 18 of the Exchange Act.
- Check the Nasdaq Global Market listing under the symbol KIDS for any subsequent announcements related to the presentation.